Search research articles
Contact Us
Filters
Showing results (101-110 of 129) with videos related to
Page
of 13
Sort By:
Blood Neoplasia
|
June 2, 2025
Venetoclax and hypomethylating agents in octogenarians and nonagenarians with acute myeloid leukemia
Ellen Madarang, Jillian Lykon, Wei Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2021
Eprenetapopt Plus Azacitidine in <i>TP53</i>-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM)
Thomas Cluzeau, Marie Sebert, Ramy Rahmé, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 15, 2015
Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasms
Brady L Stein, Jason Gotlib, Murat Arcasoy, et al.
Blood Advances
|
January 9, 2025
Advancing drug development in myelodysplastic syndromes
Alain Mina, Kathy L McGraw, Lea Cunningham, et al.
NEJM Evidence
|
February 6, 2024
Low-Dose Decitabine versus Low-Dose Azacitidine in Lower-Risk MDS
Koji Sasaki, Elias Jabbour, Guillermo Montalban-Bravo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 24, 2023
Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML
Christopher T Letson, Maria E Balasis, Hannah Newman, et al.
Journal of the American Heart Association
|
May 6, 2026
Cardiovascular Adverse Events During Venetoclax-Based Treatment in Acute Myeloid Leukemia
Sruthi Selvakumar, Sanath Shetty, Alexis Behne Sharma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2021
Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes
Aziz Nazha, Rami Komrokji, Manja Meggendorfer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 10, 2019
Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis
Roni Tamari, Franck Rapaport, Nan Zhang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 13, 2013
Myelodysplastic syndromes: clinical practice guidelines in oncology
Peter L Greenberg, Eyal Attar, John M Bennett, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 129) with videos related to
Sort By:
Page
of 13
Blood Neoplasia
|
June 2, 2025
Venetoclax and hypomethylating agents in octogenarians and nonagenarians with acute myeloid leukemia
Ellen Madarang, Jillian Lykon, Wei Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2021
Eprenetapopt Plus Azacitidine in <i>TP53</i>-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM)
Thomas Cluzeau, Marie Sebert, Ramy Rahmé, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 15, 2015
Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasms
Brady L Stein, Jason Gotlib, Murat Arcasoy, et al.
Blood Advances
|
January 9, 2025
Advancing drug development in myelodysplastic syndromes
Alain Mina, Kathy L McGraw, Lea Cunningham, et al.
NEJM Evidence
|
February 6, 2024
Low-Dose Decitabine versus Low-Dose Azacitidine in Lower-Risk MDS
Koji Sasaki, Elias Jabbour, Guillermo Montalban-Bravo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 24, 2023
Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML
Christopher T Letson, Maria E Balasis, Hannah Newman, et al.
Journal of the American Heart Association
|
May 6, 2026
Cardiovascular Adverse Events During Venetoclax-Based Treatment in Acute Myeloid Leukemia
Sruthi Selvakumar, Sanath Shetty, Alexis Behne Sharma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2021
Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes
Aziz Nazha, Rami Komrokji, Manja Meggendorfer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 10, 2019
Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis
Roni Tamari, Franck Rapaport, Nan Zhang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 13, 2013
Myelodysplastic syndromes: clinical practice guidelines in oncology
Peter L Greenberg, Eyal Attar, John M Bennett, et al.
Page
of 13